2022年度 CAPプログラム

PAP Proficiency Testing With Education

Description

Program Code (Institution)

Program Code (Individual)

Page

Calendar of Shipment Dates

PAP PT

PAPCPT (Conventional)

APAPCPT

302

Laboratory will choose one of 20 dates for testing event

Feb 7	Mar 7	April 4	May 2	June 6	July 5	Aug 1	Sept 12	Oct 17	Nov 14
Feb 22	Mar 21	April 18	May 16	June 20	July 18	Aug 15	Sept 26	Oct 31	Nov 28

PAPKPT (SurePath)

APAPKPT

302

PAPJPT (Combination)

APAPJPT

302

PAPLPT (Liquid Based)

APAPLPT

302

PAPMPT (ThinPrep)

APAPMPT

302

Education

No additional charge

Laboratory must choose from Series 1 or 2

Series 1, A mailing: February 7-February 28
Series 1, B mailing: August 8-August 29

Series 2, A mailing: May 9-May 31
Series 2, B mailing: November 7-November 28

Enrollment for laboratories with CLIA license with enrollees testing at affiliated sites

PPTENR

302

No shipments associated with this program

For additional programs for PAP PT, such as extra tests, retests, CAP provided proctors, and locum tenens, please call a Customer Contact Representative at 800-323-4040 or 847-832-7000 option 1.

PAP Education

Description	Program Code (Institution)	Program Code (Individual)	Page	Calendar of Shipment Dates
PAP Education (Series 1 or 2)	PAPCE1 or 2 (Conventional)	APAPCE1 or 2	303	Laboratory must choose from Series 1 or 2
	PAPKE1 or 2 (SurePath)	APAPKE1 or 2	303	Series 1, A mailing: February 7-February 28 Series 1, B mailing: August 8-August 29
	PAPJE1 or 2 (Combination)	APAPJE1 or 2	303
	PAPLE1 or 2 (Liquid Based)	APAPLE1 or 2	303	Series 2, A mailing: May 9-May 31 Series 2, B mailing: November 7-November 28
	PAPME1 or 2 (ThinPrep)	APAPME1 or 2	303

For international laboratories and other laboratories not subject to US regulations, that perform gynecologic cytopathology, participation in the CAP Cytopathology Glass Slide Education Program will fulfill the checklist requirement for participation in an interlaboratory peer- comparison educational program in gynecologic cytopathology.

Quality Management Tools Overview

2022 QP Studies
Modules/Packages	Program Codes
Individual QP Studies	QP211, QP222, QPC10, QPD10, QPC25, QPD25
Four QP Studies, including QP211, QP222, QPC10, QPD10	PRO

2022 QT Monitors
Modules/Packages	Program Codes
Individual Clinical Pathology (CP) Monitors	QT1, QT2, QT3, QT4, QT7, QT8, QT10, QT15, QT16, QT17
Individual Anatomic Pathology (AP) Monitor	QT5
Clinical Pathology Module – Includes all 10 CP QT Monitors	QTC
Combined CP/AP Module – Includes all 11 QT Monitors	QTP

Refer to the Quality Management Tools section of the Surveys catalog for program information.

Competency Assessment and Safety & Compliance Program

Your laboratory’s license for Competency Assessment Program is based on the number of individuals who will be using Competency Assessment Program—that is, the number of people for whom you will be assessing competency, not the number of employees in your laboratory. The Safety & Compliance course package is an addition to your Competency Assessment Program order. The same employees enrolled in Competency Assessment Program will have access to Safety & Compliance courses if the additional fee is paid.

Refer to pages 16–18 of the Surveys catalog for program information.

Number of Users*	Competency Assessment Program	Safety & Compliance Courses**
Number of Users*	Program Code	Program Code
2 to 50	CA0050	XCA0050
51 to 250	CA0250	XCA0250
251 to 500	CA0500	XCA0500
501 to 1000	CA1000	XCA1000
1001 to 1500	CA1500	XCA1500

* For subscriptions for single users or more than 1,500 users, please contact the CAP for more information.
**Safety & Compliance course package must be purchased in conjunction with Competency Assessment Program subscription.
Not available for purchase separately.

International Material Handling Information

Our programs closely mimic patient testing to ensure accuracy.

● Test specimen levels that reflect clinical decision points.
● Keep current with the latest laboratory best practices with educational content supplied in our participant summary reports.
● Gain confidence in your results by comparing your performance against the largest peer groups.

Customer Contact Center Hours: Monday–Friday, 7:00 am–5:30 pm CT
Extended Support Hours: Monday–Friday, 9:00 pm–5:00 am CT (email correspondence only)

Contact us to: Update contact and/or demographic information (laboratory name, address, contact email address, telephone and fax numbers) Receive additional supporting information or documents for ordering or importing purposes Ask a CAP expert questions about a specific CAP program	Phone: 847-832-7000 (Country code: 001) option 1 Email: Go to cap.org and select Contact & Support at the end of the homepage. OR Send an email to contactcenter@cap.org
Laboratory Accident Hotline Accidental exposures while processing specimens from the CAP, including cuts and contamination of mucous membranes or non-intact skin, should be reported to the CAP hotline for evaluation and questions regarding prophylaxis. Please provide the identification number of the relevant specimen.	847-832-7000 (Country code: 001) – During Contact Center hours 847-470-2812 (Country code: 001) – All other hours
In countries where the CAP has a designated distributor, directly contact your CAP distributor if you have questions related to pricing or any other inquiry not listed above. If you are unsure if your country has a designated distributor, go to cap.org for more information. Under the Laboratory Improvement tab, click on International Laboratories.

e-LAB Solutions Suite
Use the CAP’s online portal to manage your laboratory improvement programs. The portal provides helpful, convenient, and easy-to-use tools to:

Access the CAP’s web-based reporting solution, Performance Analytics Dashboard.
Enter, review, and approve your proficiency testing (PT), also referred to as external quality assessment (EQA), results with interactive online forms.
View and print copies of evaluations, participant summary reports, kit instructions, and result forms.
Access your analyte scorecard, customized PT shipping calendar, and other analytical tools.
Manage your laboratory’s online access, user permissions, and your individual profile.
Manage your laboratory’s accreditation documents, including customized accreditation checklists and test menu/activity change forms.
Enhance your automated reporting capabilities with e-LAB Solutions Connect (available in the US and Canada).
Connect to CAP Learning tools, assessments, and modules.

This site contains a Users Guide that will guide you through the process of using e-LAB Solutions Suite. When you enroll/register for e-LAB Solutions Suite, your laboratory will receive important email notifications regarding PT events such as kit and evaluation availability.

Program Certificates
At the completion of the CAP program year, participating laboratories will receive a program certificate that recognizes each institution’s participation in the CAP Surveys and Anatomic Pathology Education Programs. This certificate is an indication of your commitment to quality improvement for better patient care.
Program Usage and Materials

All program materials are intended for PT use only.
You may not transfer or incorporate PT samples, their progeny, unmodified derivatives, or modifications thereof into a program intended for sale or uses other than PT, quality assurance, or education.
When you dispose of PT samples, their progeny, unmodified derivatives, or modifications thereof, reagents, and disposable equipment used in PT, you should autoclave or incinerate and dispose of these items as hazardous waste.
All directions concerning use of the program materials are intended as guidance only.
No license is either granted or implied by the sale of any program.
It is the CAP’s policy to only use donor-based specimens when informed consent has been obtained in conjunction with internal review board approval by the collection facility.
The CAP contracts with several vendors in producing the materials for its PT programs.
TheCAPfollowsPTmanufacturerdirectionsfordeterminationoftransportpackingandshippingconditions.These requirements may differ from the in-laboratory storage specifications indicated in the kit instructions that accompany your PT.
Upon delivery of your PT, follow the kit instructions immediately and conduct testing as soon as possible.

Biohazard Information/Warning Statements

The Centers for Disease Control and Prevention (CDC) has classified all bacterial and viral strains used in PT challenges as not greater than a Biosafety Level 2. You can find a full description of Biosafety Level 2 handling requirements, as defined by the CDC Office of Health and Safety in Biosafety in Microbiological and Biomedical Laboratories, at cdc.gov/biosafety/publications/bmbl5/index.html.
All programs include a biohazard warning statement appropriate for handling of the material.
Programs that do not include etiologic agents are still expected to be handled in keeping with CDC universal precautions and Occupational Safety and Health Administration (OSHA) bloodborne pathogen rules.
The CAP’s Safety Data Sheets (SDS/MSDS) are available on cap.org (Laboratory Improvement > Catalog and Ordering Information).

PT Referral
Laboratories must not communicate results, share PT specimens, or refer PT specimens to another laboratory for tests not on the laboratory’s menu even if the referral for testing is routinely performed for patient specimens.

Additional Information for International Participants to Ensure Timely Delivery of PT Programs

Permits and Clearance Documentation
Some countries may require additional import permits or certificates of origin for customs clearance (regardless of dangerous goods status of a program).

Work with your in-country distributor (if applicable) and local authorities to determine if any permits are required.
As a recipient, you are responsible for obtaining any import permits/documents and forwarding these to the CAP or your local distributor (if applicable) for customs clearance at the port of entry. Provide all necessary documents to your broker, carrier, and/or customs authorities in a timely manner. The CAP will not be responsible for providing replacement shipments due to lengthy clearance delays due to lack of paperwork.
Do not use the CAP Surveys catalog program descriptions for permit preparation and customs clearance documents. Program specifications may have changed after catalog publication and do not provide sufficient detail. Ask your in-country distributor (if applicable) or reach out to the CAP Customer Contact Center for questions of this nature.
Programs with dangerous goods materials may require special permits and incur additional shipping and handling charges.
You are responsible for monitoring permit expiration dates and submitting a new permit a minimum of six weeks prior to the scheduled ship date, and preferably at the time of ordering. Check with your local governmental importation authorities or your in-country distributor (if applicable), which may have longer lead time requirements and adjust your permit obligations accordingly.
Permits should contain an extended expiration date of December 31, 2022, in order to cover all shipments.
Program materials will not ship without required documentation.

Additional Documentation
Contact the CAP Customer Data Management (CDM) department at cdm@cap.org if you require additional documentation to place orders or receive shipments. Examples of available documentation include: US IRS Form 6166 Certificate of Residency, Articles of Incorporation, and the CAP’s tax status. Material and Safety Data Sheets are available at cap.org.

Contact your local customs agency for importation requirements.

Programs Classified as UN3373 Dangerous Goods
Program Code	Program Name	Program Code	Program Name
BCS	Blood Culture	HPS	Helicobacter pylori Antigen, Stool
BCS1	Blood Culture, Staphylococcus aureus	IDN	Nucleic Acid Amplification, Organisms without MTB
BDP, BDP5	Bacterial Detection in Platelets	IDO	Nucleic Acid Amplification, Organisms
BDPV, BDPV5	Bacterial Detection in Platelets, Rapid	LN38	CMV Viral Load Calibration Verification/ Linearity
CAMP	Campylobacter	LPX	Laboratory Preparedness Exercise
CBT	Cord Blood Testing	MBT	Microbiology Bench Tools Competency
D	Bacteriology	MC3	Urine Colony Count
DEX	Expanded Bacteriology	MC4	Urine Colony Count Combination
D1	Throat Culture	MRS	Methicillin-resistant Staphylococcus aureus Screen
D2	Urine Culture	MRS5	Methicillin-resistant Staphylococcus aureus Screen, 5 Challenge
D3	N. gonorrhoeae Culture	RMC	Routine Microbiology Combination
D8	Group B Strep Detection	SCP	Stem Cell Processing
E	Mycobacteriology	VR1	Virology Culture
E1	Mycobacteriology—Limited	VRE	Vancomycin-resistant Enterococcus
F	Mycology	VS	Vaginitis Screen Antigen Detection – BD Affirm VP III
F1	Yeast
F3	Candida Culture
HC4	Herpes Culture
HC6, HC6X	C. trachomatis and N. gonorrhoeae by NAA

WARNING: The Instrumentation (I) program specimens may contain corrosive or toxic substances, environmental hazards, or irritants. This program ships under a UN3264 Class 9 Dangerous Goods Classification in Excepted Quantities with a specimen volume below the threshold requiring special packaging.
Note: CAP Viral Measures VM1-VM6X do not ship under a Dangerous Goods Classification; however, some countries may still require permits due to the nature of the material.
Stability
Some programs have limited stability and may not be available in certain countries. For more information, contact the CAP Customer Contact Center.

Programs With Stability Between 3 and 10 Days
Program Code	Program Name
B27	HLA-B27 Typing
EPO	Erythropoietin
GH2, GH5	Hemoglobin A1c
HFC	Hemocytometer Fluid Count
LN15	Hemoglobin A1c Calibration Verification/Linearity
MXB	HLA Crossmatching, Antibody Screen, and Identification (Class I and II)
MXC	HLA Crossmatching, Antibody Screen, and Identification (Class I and II)
MXE	HLA Antibody Screen and Identification (Class I and II)

For CAP-accredited non-US laboratories, the CAP requests that your laboratory perform testing on these materials. If unacceptable results are achieved and it is established that such results are due to shipping conditions, your laboratory may review options with the CAP Laboratory Accreditation Program at accred@cap.org.

Programs With 2 Days or Less Stability
Program Code	Program Name
BALL	B-Cell Acute Lymphocytic Leukemia
CBT	Cord Blood Testing
FL3	Flow Cytometry, Immunophenotypic Characterization of Leukemia/Lymphoma
FL8	Flow Cytometry, Mature B-Cell Leukemia/Lymphoma Minimal Residual Disease
FL9	Flow Cytometry, Plasma Cell Myeloma Minimal Residual Disease
PCNEO	Flow Cytometry, Plasma Cell Neoplasmas
RFAV1	Rare Flow Antigen Validation, CD1a
RFAV3	Rare Flow Antigen Validation, CD30
SCP	Stem Cell Processing
ZAP70	ZAP-70 Analysis by Flow Cytometry

These programs have stability of two days or less. The CAP cannot guarantee performance or offer credits for orders placed for shipment outside of the US and Canada.

Note: The CAP strives to deliver all program materials in a stable condition. Programs that must be kept cold will ship with frozen cold packs or dry ice as needed and allowed by country importation regulations. If transportation to your location cannot meet these conditions, please note that replacements will not be available.
Dry Ice Some shipments are packed on dry ice to maintain stability. Dry ice shipments are shipped as UN1845 dangerous goods shipments. Due to sublimation, there may not be any dry ice present when you open your kit. This condition is not an indication that the program material has been compromised. If your country does not allow dry ice shipments, your program material will be packaged with cool packs that may not be as effective in maintaining a cool environment. When you receive your shipment, follow the kit storage instructions immediately to avoid compromising the program material.

Programs With 2 Days or Less Stability
Program Code	Program Name
ABGIC	Accuracy-Based Glucose, Insulin, and C-Peptide
ABL	Accuracy-Based Lipids
ABS	Accuracy-Based Testosterone, Estradiol
ABTH	Harmonized Thyroid
ABU	Accuracy-Based Urine
ABVD	Accuracy-Based Vitamin D
ACA	Antichromatin Antibody
AFD	Antifungal Drugs Monitoring
AG*	1,5-Anhydroglucitol
ARP	Antiribosomal P Antibody
BDPV, BDPV5	Bacterial Detection in Platelets, Rapid
BGL, BGL1, BGL2	CAP/ACMG Biochemical Genetics
BMV2*	Bone Specific Alkaline Phosphatase
BNP, BNP5	B-Type Natriuretic Peptides
BU*	Bone and Mineral Metabolism, Urine
C1, C3/C3X, C4, CZ/CZX, CZ2X/CZVM, Z*	Chemistry and Therapeutic Drug Monitoring
C7*	Pseudocholinesterase
CMSP	CAP/ACMG Cardiomyopathy Sequencing Panel
CNVST	Copy Number Variant Solid Tumor
CRT, CRTI	Cardiac Markers
CRTQ	Quality Cross Check—Cardiac Markers
CS	CAP/AACC Immunosuppressive Drugs
CYS*	Cystatin C
CZQ*	Quality Cross Check—Chemistry/Therapeutic Drug Monitoring
DAI*	Urine Drug Adulterant/Integrity Testing
DMPM*	Drug Monitoring for Pain Management
EPO*	Erythropoietin
EV	Everolimus
FOL*	RBC Folate
FT*	Fructosamine
FTC*	Forensic Toxicology, Criminalistics
GSA*	Glycated Serum Albumin
HCRT, HCRTI	High-Sensitivity Cardiac Markers
HCV2	Hepatitis C Viral Load
HIVG	HIV Genotyping
HV2	HIV Viral Load
ICSP	CAP/ACMG Inherited Cancer Sequencing Panel
IFS*	Interfering Substances
IGHV	IGHV Mutation Analysis
ING*	Insulin, Gastrin, C-Peptide, and PTH
K, KK, KVM*	Ligand Assay—General
KET	Ketones
LCW	Chemistry—Limited, Waived
LN2, LN2BV	Chemistry Calibration Verification/Linearity
LN24	Creatinine Accuracy Calibration Verification/Linearity
LN25, LN27	Troponin Calibration Verification/Linearity
LN30	B-Type Natriuretic Peptides Calibration Verification/Linearity
LN31	Immunosuppressive Drugs Calibration Verification/Linearity
LN35, LN36, LN37	Coagulation Calibration Verification/Linearity
LN38	CMV Viral Load Calibration Verification/Linearity
LN41	Procalcitonin Calibration Verification/Linearity
LN44	Fibrinogen Calibration Verification/Linearity
LN45	HCV Viral Load Calibration Verification/Linearity
LN46	C-Peptide/Insulin Calibration Verification/Linearity
LN47*	High-Sensitivity Troponin T Calibration Verification/Linearity
LN5, LN5S	Ligand Calibration Verification/Linearity
LPE*	Lipoprotein Electrophoresis
MHO, MHO1, MHO2, MHO3	Molecular Hematologic Oncology
MPA	Mycophenolic Acid
MRD, MRD1, MRD2	Minimal Residual Disease
NAT	Nucleic Acid Testing
NB, NB2	Neonatal Bilirubin
NOB	Novel Opioids and Benzodiazepines
NTA	Nicotine and Tobacco Alkaloids
OFD*	Oral Fluid for Drugs of Abuse
PCARI, PCARM, PCARMX	Plasma Cardiac Markers
RAP*	Renin and Aldosterone
RNA	Fusion RNA Sequencing
SALC	Salivary Cortisol
SARC	Sarcoma Fusion Gene
SCDD*	Synthetic Cannabinoid/Designer Drugs
SCO*	Serum Carryover
T*	Toxicology
TBLA	Total Bile Acids
TM, TMX	Tumor Markers
TMB	Tumor Mutational Burden
UDS, UDSM, UDS6*	CAP/AACC Urine Drug Testing, Screening
UPBG	Porphobilinogen, Urine
UT, UTCO	Urine Toxicology Carryover
VF*	Vitreous Fluid, Postmortem
VITD*	25-OH Vitamin D, Total
Y, YY, YVM*	Sex Hormones
ZE*	Therapeutic Drug Monitoring—Extended

*This program ships with a cool pack to laboratories in the US, Puerto Rico, Guam, Virgin Islands, American Samoa, and to APO/FPO addresses.

Options for International Customers
If you are ordering programs shipped with dry ice or cool packs and the average temperature in your country is higher than 25°C (77°F), the CAP recommends you upgrade your shipment packaging to the extended shipper (XDS). The XDS is a dual insulation shipper intended to maintain the cold chain to destinations with warmer climates. The fee associated with such service is $30 per program.
Contact our Customer Contact Center at contactcenter@cap.org or 847-832-7000
(Country code:001) to upgrade to the XDS.